Stavroula Kyriakaki
Irakleion, ESYE43, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Dysregulation of lncRNA MEG3/miR-21-5p Axis Impairs SOX5 Expression in Osteoarthritis.
Journal: Genes
Published: May 07, 2026
Comparative analysis of mortality patterns and treatment strategies in thalassaemia and sickle cell disease patients: A 12-year study.
Journal: British journal of haematology
Published: December 03, 2024
Serum Levels of Soluble FLT3 Ligand in Patients with Active Multiple Myeloma Constitute Marker of Bone Marrow Plasma Cell Proliferative Activity.
Journal: Critical reviews in oncogenesis
Published: January 01, 2017
Potential role of FLT3-ligand in the angiogenic process of multiple myeloma.
Journal: Leukemia research
Published: July 06, 2015
Clinical aspects of malt lymphomas.
Journal: Current hematologic malignancy reports
Published: September 22, 2014
New insights into monoclonal B-cell lymphocytosis.
Journal: BioMed research international
Published: April 17, 2014
Circulating levels of soluble Fas ligand reflect disease progression in multiple myeloma.
Journal: Medical oncology (Northwood, London, England)
Published: March 10, 2014
Increased serum levels of MIP-1alpha correlate with bone disease and angiogenic cytokines in patients with multiple myeloma.
Journal: Medical oncology (Northwood, London, England)
Published: September 23, 2013
The relationship between soluble receptor of interleukin-6 with angiogenic cytokines and proliferation markers in multiple myeloma.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: September 29, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026